You are using an outdated browser. Please upgrade your browser to improve your experience.
UroSpot

Oncology drugs can be a direct cause of renal insufficiency and failure during treatment*

Oncology drugs can be a direct cause of renal insufficiency and failure during treatment*

UroSpot

by Swiss Safe Collect SA
UroSpot
UroSpot
UroSpot

What is it about?

Oncology drugs can be a direct cause of renal insufficiency and failure during treatment*. Vascular damage, with direct toxicity to the glomerular & tubule function can cause, among others, severe electrolyte disturbance.

UroSpot

App Details

Version
1.1
Rating
NA
Size
77Mb
Genre
Health & Fitness Medical
Last updated
October 21, 2020
Release date
September 12, 2020
More info

App Screenshots

UroSpot screenshot-0
UroSpot screenshot-1
UroSpot screenshot-2
UroSpot screenshot-3
UroSpot screenshot-4

App Store Description

Oncology drugs can be a direct cause of renal insufficiency and failure during treatment*. Vascular damage, with direct toxicity to the glomerular & tubule function can cause, among others, severe electrolyte disturbance.



These renal issues caused by the interactions between cancer and the kidney may require dosage adjustment of anticancer drugs in order to avoid drug accumulation and long term side-effects.



Our full service provides a unique early warning system for oncology patients during treatment. We collect and eco-process urine of patients to avoid toxic molecules being circulated in the water supply, on top of ensuring urine data transmission via our urine collector and native application to the patient’s treatment group.

During the period of urinary elimination of the therapy molecules, our collector allows patients to urinate fully, autonomously and with dignity at home or at the hopsital without impacting the environment or people around them.

Thanks to the simple handling of our native application, patients can easily facilitate the monitoring of their treatment, thus guaranteeing a precise follow-up of their kidney’s health by their Treatment Groups.



*Source :

• http://sitegpr.com/fr/rein/en-savoir-plus/oncologie-et-insuffisance-renale/

• Launay-Vacher V, Oudard S, Janus N, et al. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 2007; 110:1376–1384.

• Launay-Vacher V. Epidemiology of chronic kidney disease in cancer patients: lessons from the IRMA study group. Semin. Nephrol. 2010; 30:548–556.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.